University of Hertfordshire

From the same journal

  • Ellen Bible
  • Omar Qutachi
  • David Y.S. Chau
  • Morgan R. Alexander
  • Kevin M. Shakesheff
  • Michel Modo
View graph of relations
Original languageEnglish
Pages (from-to)7435-7446
Number of pages11
JournalBiomaterials
Volume33
Issue30
DOIs
Publication statusPublished - Oct 2012

Abstract

Replacing the tissue lost after a stroke potentially provides a new neural substrate to promote recovery. However, significant neurobiological and biotechnological challenges need to be overcome to make this possibility into a reality: Human neural slim cells (hNSCs) can differentiate into mature brain cells, but require a-structural support that retains them within the cavity and affords the formation of a de novo tissue: Nevertheless; in our previous work even after a week, this primitive tissue is void of a vasculature that could sustain its long-term viability. Therefore, tissue engineering strategies are required to develop a vasculature. Vascular endothelial growth factor (VEGF) is known to promote the proliferation and migration of endothelial cells during angio- and arteriogenesis. VEGF by itself here did not affect viability or differentiation of hNSCs, whereas growing cell on poly(D,L-lactic acid-co-glycolic acid) (PLGA) microparticles, with or without VEGF, doubled astrocytic and neuronal differentiation. Secretion of a burst and a sustained delivery of VEGF from the microparticles in vivo attracted endothelial cells from the host into this primitive tissue and in parts established a neovasculature, whereas in other parts endothelial cells were merely interspersed with hNSCs. There was also evidence of a hypervascularization-indicating. that further work will be required to establish an adequate level of vascularization. It is therefore possible to develop a putative neovasculature within de novo tissue that is forming inside a tissue cavity caused by a stroke. (C) 2012 Elsevier Ltd. All rights reserved.

ID: 2585141